Family · Pharmaceutical analytical standards
Edoxaban
An oral anticoagulant that directly and selectively blocks clotting factor Xa. It is used to prevent stroke and embolism in non-valvular atrial fibrillation and to treat deep vein thrombosis and pulmonary embolism; it reached the market in Europe and the United States in 2015. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It was first approved in 2011 in Japan, where it was developed, to prevent blood clots after lower-limb orthopaedic surgery such as hip and knee replacement.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
